CD8A and neoplasm: Accordingly, the molecular group can be predictive of the composition of the TIME; 83% of SHH MB tumours feature higher proportions of B cells and CD8+ T cells, while Group 3 and Group 4 tumours largely comprise low amounts of infiltrating CD8+ T cells, and otherwise have no significant skew towards a particular immune cell type.